1,008 research outputs found

    Effect of gaseous and solid simulated jet plumes on a 040A space shuttle launch configuration at Mach numbers from 1.6 to 2.2

    Get PDF
    An experimental investigation was conducted in a 9- by 7-foot supersonic wind tunnel to determine the effect of plume-induced flow separation and aspiration effects due to operation of both the orbiter and the solid rocket motors on a 0.019-scale model of the launch configuration of the space shuttle vehicle. Longitudinal and lateral-directional stability data were obtained at Mach numbers of 1.6, 2.0, and 2.2 with and without the engines operating. The plumes exiting from the engines were simulated by a cold gas jet supplied by an auxiliary 200 atmosphere air supply system, and by solid body plume simulators. Comparisons of the aerodynamic effects produced by these two simulation procedures are presented. The data indicate that the parameters most significantly affected by the jet plumes are the pitching moment, the elevon control effectiveness, the axial force, and the orbiter wing loads

    Implications of future northwest Atlantic bottom temperatures on the American lobster (Homarus americanus) fishery

    Get PDF
    © The Author(s), 2017. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Journal of Geophysical Research: Oceans 122 (2017): 9387–9398, doi:10.1002/2017JC012949.Sea surface temperatures of the northwest Atlantic have warmed dramatically over the last several decades, while benthic temperatures have increased at a slower pace. Here we analyze a subset of the CMIP5 global Earth system model ensemble using a statistical downscaling approach to determine potential future changes in benthic temperatures on the northwest Atlantic continental shelf and slope (<500 m). We put future changes in the context of possible impacts of ocean warming on the high-value, wild-caught American Lobster (Homarus americanus) fishery. Future bottom temperatures of the northwest Atlantic under a business-as-usual (RCP8.5) and a climate-policy (RCP4.5) scenario are projected to increase by 0–1.5°C and 1.2–2.4°C by 2050 and 0–1.9°C and 2.3–4.3°C by the end of the century for RCP4.5 and RCP8.5, respectively. H. americanus experiences thermal stress at temperatures above 20°C, and projected increases in temperature is likely to result in changes in the distribution of optimal thermal egg hatching and settlement indicators. Inshore regions of southern New England, where H. americanus biomass and catch have been declining historically, will likely become inhospitable under either future scenario, while thermal egg hatching and settlement indicators will expand offshore and in the Gulf of Maine. These changes imply that members of the fishery based in southern New England may need to recapitalize to larger vessels to prepare for potential changes brought on by future climate warming. Results from the downscaling presented here can be useful in preparing for potential changes to other fisheries or in future climate vulnerability analyses.John D. and Catherine T. MacArthur Foundation Grant Number: 14-106159-000-CFP; NASA Grant Number: NNX14AP62A; “National Marine Sanctuaries as Sentinel Sites for a Demonstration Marine Biodiversity Observation Network (MBON)”; National Ocean Partnership Program Grant Number: NOPP RFP NOAA-NOS IOOS-2014-2003803; NOAA Integrated Ocean Observing System (IOOS) Program Offic

    Structure and function of human hemoglobin covalently labeled with periodate-oxidized adenosine triphosphate

    Get PDF
    Periodate-oxidized adenosine triphosphate (o-ATP), a ribose ring-opened dialdehyde derivative of ATP, reacts specifically with human deoxyhemoglobin to give a single major covalently modified product after reduction with sodium borohydride. This product, designated di-ATP Hb, was isolated using ion-exchange chromatography and shown to have incorporated two molecules of o-ATP/tetramer. Peptide mapping and x-ray crystallography at 2.8-A resolution indicate that a covalent adduct is formed between the ligand and residues Lys-82 EF6 of each beta chain in the organic phosphate-binding site of the molecule. di-ATP Hb exhibits a significantly decreased oxygen affinity (P50 = 20.8 mm Hg versus 5.8 mm Hg control; 50 mM 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-propane-1,3-diol, pH 7.4, 0.1 M C, 20 degrees C). The subunit cooper-activity of di-ATP Hb is also reduced (nmax = 1.9 versus 2.7 control)

    Variability in the mechanisms controlling Southern Ocean phytoplankton bloom phenology in an ocean model and satellite observations

    Get PDF
    Author Posting. © American Geophysical Union, 2017. This article is posted here by permission of American Geophysical Union for personal use, not for redistribution. The definitive version was published in Global Biogeochemical Cycles 31 (2017): 922–940, doi:10.1002/2016GB005615.A coupled global numerical simulation (conducted with the Community Earth System Model) is used in conjunction with satellite remote sensing observations to examine the role of top-down (grazing pressure) and bottom-up (light, nutrients) controls on marine phytoplankton bloom dynamics in the Southern Ocean. Phytoplankton seasonal phenology is evaluated in the context of the recently proposed “disturbance-recovery” hypothesis relative to more traditional, exclusively “bottom-up” frameworks. All blooms occur when phytoplankton division rates exceed loss rates to permit sustained net population growth; however, the nature of this decoupling period varies regionally in Community Earth System Model. Regional case studies illustrate how unique pathways allow blooms to emerge despite very poor division rates or very strong grazing rates. In the Subantarctic, southeast Pacific small spring blooms initiate early cooccurring with deep mixing and low division rates, consistent with the disturbance-recovery hypothesis. Similar systematics are present in the Subantarctic, southwest Atlantic during the spring but are eclipsed by a subsequent, larger summer bloom that is coincident with shallow mixing and the annual maximum in division rates, consistent with a bottom-up, light limited framework. In the model simulation, increased iron stress prevents a similar summer bloom in the southeast Pacific. In the simulated Antarctic zone (70°S–65°S) seasonal sea ice acts as a dominant phytoplankton-zooplankton decoupling agent, triggering a delayed but substantial bloom as ice recedes. Satellite ocean color remote sensing and ocean physical reanalysis products do not precisely match model-predicted phenology, but observed patterns do indicate regional variability in mechanism across the Atlantic and Pacific.NDSEG Graduate Fellowship; National Aeronautics and Space Administration Ocean Biology and Biogeochemistry Program Grant Number: NNX14L86G; NSF Poloar Programs Award Grant Number: 1440435; National Aeronautics and Space Administration Grant Number: NNX14AL86G; NDSEG; National Science Foundation Grant Number: 14404352017-11-3

    Thirty-three years of ocean benthic warming along the U.S. Northeast Continental Shelf and Slope : patterns, drivers, and ecological consequences

    Get PDF
    © The Author(s), 2017. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Journal of Geophysical Research: Oceans 122 (2017): 9399–9414, doi:10.1002/2017JC012953.The U.S. Northeast Continental Shelf is experiencing rapid warming, with potentially profound consequences to marine ecosystems. While satellites document multiple scales of spatial and temporal variability on the surface, our understanding of the status, trends, and drivers of the benthic environmental change remains limited. We interpolated sparse benthic temperature data along the New England Shelf and upper Slope using a seasonally dynamic, regionally specific multiple linear regression model that merged in situ and remote sensing data. The statistical model predicted nearly 90% of the variability of the data, resulting in a synoptic time series spanning over three decades from 1982 to 2014. Benthic temperatures increased throughout the domain, including in the Gulf of Maine. Rates of benthic warming ranged from 0.1 to 0.4°C per decade, with fastest rates occurring in shallow, nearshore regions and on Georges Bank, the latter exceeding rates observed in the surface. Rates of benthic warming were up to 1.6 times faster in winter than the rest of the year in many regions, with important implications for disease occurrence and energetics of overwintering species. Drivers of warming varied over the domain. In southern New England and the mid-Atlantic shallow Shelf regions, benthic warming was tightly coupled to changes in SST, whereas both regional and basin-scale changes in ocean circulation affect temperatures in the Gulf of Maine, the Continental Shelf, and Georges Banks. These results highlight data gaps, the current feasibility of prediction from remotely sensed variables, and the need for improved understanding on how climate may affect seasonally specific ecological processes.John D. and Catherine T. MacArthur Foundation Grant Number: 14–106159-000-CFP; National Aeronautics and Space Administration Grant Number: NNX14AP62

    Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

    Get PDF
    Background: Interleukin 17A is a proinflammatory cytokine that is implicated in the pathogenesis of psoriatic arthritis. We assessed the efficacy and safety of subcutaneous secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis. Methods: In this phase 3, double-blind, placebo-controlled study undertaken at 76 centres in Asia, Australia, Canada, Europe, and the USA, adults (aged &#8805;18 years old) with active psoriatic arthritis were randomly allocated in a 1:1:1:1 ratio with computer-generated blocks to receive subcutaneous placebo or secukinumab 300 mg, 150 mg, or 75 mg once a week from baseline and then every 4 weeks from week 4. Patients and investigators were masked to treatment assignment. The primary endpoint was the proportion of patients achieving at least 20% improvement in the American College of Rheumatology response criteria (ACR20) at week 24. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01752634. Findings: Between April 14, and Nov 25, 2013, 397 patients were randomly assigned to receive secukinumab 300 mg (n=100), 150 mg (n=100), 75 mg (n=99), or placebo (n=98). A significantly higher proportion of patients achieved an ACR20 at week 24 with secukinumab 300 mg (54 [54%] patients; odds ratio versus placebo 6·81, 95% CI 3·42–13·56; p&#60;0·0001), 150 mg (51 [51%] patients; 6·52, 3·25–13·08; p&#60;0·0001), and 75 mg (29 [29%] patients; 2·32, 1·14–4·73; p=0·0399) versus placebo (15 [15%] patients). Up to week 16, the most common adverse events were upper respiratory tract infections (four [4%], eight [8%], ten [10%], and seven [7%] with secukinumab 300 mg, 150 mg, 75 mg, and placebo, respectively) and nasopharyngitis (six [6%], four [4%], six [6%], and eight [8%], respectively). Serious adverse events were reported by five (5%), one (1%), and four (4%) patients in the secukinumab 300 mg, 150 mg, and 75 mg groups, respectively, compared with two (2%) in the placebo group. No deaths were reported. Interpretation: Subcutaneous secukinumab 300 mg and 150 mg improved the signs and symptoms of psoriatic arthritis, suggesting that secukinumab is a potential future treatment option for patients with this disorder

    Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis.

    Get PDF
    OBJECTIVE: To determine the duration of clinical benefit among patients with psoriatic arthritis (PsA) discontinuing tumour necrosis factor inhibitor (TNFi) therapy while in low disease activity (LDA), and to identify patient characteristics associated with prolonged clinical benefit. METHODS: We performed an observational cohort study assessing patients with PsA from the Consortium of Rheumatology Researchers of North America (CORRONA) registry who had discontinued TNFi after achieving LDA, defined as clinical disease activity index (CDAI) score ≤10 and physician\u27s global assessment (PGA) of skin psoriasis ≤20/100. Kaplan-Meier method was used to estimate the duration of clinical benefit. RESULTS: Of the 5945 patients with PsA in CORRONA, 302 patients had discontinued TNFi (n=325) while in LDA and had follow-up data available. At time of discontinuation, mean PsA duration was 9.8 years, mean CDAI was 3.9, and mean duration of TNFi use was 1.5 years; 52.6% of patients had discontinued their first TNFi. Median time to loss of benefit was 29.2 months. 179 (55.1%) patients had persistent benefit at their previous clinic visit. An increased risk of losing clinical benefit was seen among patients with higher disease activity at discontinuation (CDAI≥3.2 vs CONCLUSIONS: Patients with PsA who achieve LDA may maintain clinical benefit after discontinuation of TNFi therapy

    Treatment recommendations for psoriatic arthritis

    Get PDF
    Objective: To develop comprehensive recommendations for the treatment of the various clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic review of the literature and from consensus opinion. Methods: Formal literature reviews of treatment for the most significant discrete clinical manifestations of PsA (skin and nails, peripheral arthritis, axial disease, dactylitis and enthesitis) were performed and published by members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Treatment recommendations were drafted for each of the clinical manifestations by rheumatologists, dermatologists and PsA patients based on the literature reviews and consensus opinion. The level of agreement for the individual treatment recommendations among GRAPPA members was assessed with an online questionnaire. Results: Treatment recommendations were developed for peripheral arthritis, axial disease, psoriasis, nail disease, dactylitis and enthesitis in the setting of PsA. In rotal, 19 recommendations were drafted, and over 80% agreement was obtained on 16 of them. In addition, a grid that factors disease severity into each of the different disease manifestations was developed to help the clinician with treatment decisions for the individual patient from an evidenced-based perspective. Conclusions: Treatment recommendations for the cardinal physical manifestations of PsA were developed based on a literature review and consensus between rheumatologists and dermatologists. In addition, a grid was established to assist in therapeutic reasoning and decision making for individual patients. It is anticipated that periodic updates will take place using this framework as new data become available
    • …
    corecore